Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-14

Clinical Trial Update: Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety and efficacy of Bepotastine Besilate Nasal Spray for seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bepotastine besilate nasal spray (bepotastine besilate nasal spray)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2020-09-14